Free Trial

Neumora Therapeutics (NMRA) SEC Filings & 10K Form

Neumora Therapeutics logo
$1.74 +0.01 (+0.58%)
Closing price 09/2/2025 04:00 PM Eastern
Extended Trading
$1.72 -0.02 (-0.92%)
As of 09/2/2025 06:15 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Neumora Therapeutics SEC Filings

DateFilerForm TypeView
08/06/2025
3:31 PM
Neumora Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/30/2025
5:25 PM
Neumora Therapeutics (Issuer)
Pinto Joshua (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2025
5:30 PM
Halawa Alaa (Reporting)
Neumora Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2025
5:30 PM
Ho Maykin (Reporting)
Neumora Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2025
5:30 PM
BERNS PAUL L (Reporting)
Neumora Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2025
5:30 PM
Neumora Therapeutics (Issuer)
Piacquad David (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2025
5:30 PM
Aurora Daljit Singh (Reporting)
Neumora Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2025
5:30 PM
Burow Kristina (Reporting)
Neumora Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2025
5:30 PM
Fust Matthew K (Reporting)
Neumora Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2025
5:30 PM
Duncan Jason (Reporting)
Neumora Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2025
5:31 PM
Milligan Michael Lee (Reporting)
Neumora Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2025
4:21 PM
Neumora Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/23/2025
3:42 PM
Neumora Therapeutics (Issuer)
Pinto Joshua (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/26/2025
11:15 PM
Neumora Therapeutics (Filer)
Form EFFECT
03/12/2025
3:49 PM
Gosebruch Henry O (Reporting)
Neumora Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/03/2025
3:41 PM
Neumora Therapeutics (Filer)
Form POS AM
03/03/2025
3:44 PM
Neumora Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/03/2025
6:32 AM
Neumora Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/03/2025
6:06 AM
Neumora Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/03/2025
6:12 AM
Neumora Therapeutics (Filer)
Form POSASR
02/20/2025
4:11 PM
Neumora Therapeutics (Issuer)
Pinto Joshua (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/20/2025
4:12 PM
Lenz Robert A. (Reporting)
Neumora Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/20/2025
4:13 PM
Aurora Daljit Singh (Reporting)
Neumora Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/20/2025
4:14 PM
Milligan Michael Lee (Reporting)
Neumora Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/20/2025
4:14 PM
BERNS PAUL L (Reporting)
Neumora Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2025
3:30 PM
Halawa Alaa (Reporting)
Neumora Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2025
3:30 PM
Duncan Jason (Reporting)
Neumora Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2025
3:30 PM
Neumora Therapeutics (Issuer)
Pinto Joshua (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2025
3:30 PM
Milligan Michael Lee (Reporting)
Neumora Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2025
3:30 PM
Burow Kristina (Reporting)
Neumora Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2025
3:30 PM
Neumora Therapeutics (Issuer)
Piacquad David (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2025
3:30 PM
Fust Matthew K (Reporting)
Neumora Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2025
3:30 PM
Aurora Daljit Singh (Reporting)
Neumora Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2025
3:30 PM
Ho Maykin (Reporting)
Neumora Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2025
3:30 PM
Lenz Robert A. (Reporting)
Neumora Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2025
3:30 PM
BERNS PAUL L (Reporting)
Neumora Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2025
3:51 PM
Neumora Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/13/2025
7:00 AM
Neumora Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/02/2025
6:10 AM
Neumora Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/27/2024
4:01 PM
BERNS PAUL L (Reporting)
Neumora Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/22/2024
4:33 PM
ARCH Venture Fund XII, L.P. (Filed by)
Neumora Therapeutics (Subject)
Form SC 13D/A
"I'm risking my reputation on this" (Ad)

A massive supply shock is building in the crypto market that could send Bitcoin to $300,000 this year. That's why we've rushed to update our book "Crypto Revolution" – to show you exactly how to position yourself for this historic opportunity.tc pixel

Click here to claim your FREE copy now!
11/12/2024
6:17 AM
Neumora Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/18/2024
5:25 PM
Fust Matthew K (Reporting)
Neumora Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/18/2024
3:01 PM
Fust Matthew K (Reporting)
Neumora Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/17/2024
3:26 PM
Fust Matthew K (Reporting)
Neumora Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/11/2024
3:10 PM
Lenz Robert A. (Reporting)
Neumora Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/10/2024
3:30 PM
Lenz Robert A. (Reporting)
Neumora Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/09/2024
3:10 PM
Lenz Robert A. (Reporting)
Neumora Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/01/2024
4:22 PM
Neumora Therapeutics (Filer)
Form S-3ASR
09/19/2024
3:35 PM
Lenz Robert A. (Reporting)
Neumora Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/17/2024
3:37 PM
Lenz Robert A. (Reporting)
Neumora Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/13/2024
4:22 PM
Aurora Daljit Singh (Reporting)
Neumora Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/12/2024
4:18 PM
Lenz Robert A. (Reporting)
Neumora Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:NMRA) was last updated on 9/3/2025 by MarketBeat.com Staff
From Our Partners